Issue archive · 2026

Volume 1, Issue 1 (2026)

Articles: 5

Volume 1, Issue 1 (2026)

Inaugural issue · Third quarter 2026

Volume 1 · Issue 1 · 2026

Published: · Articles: 5

Complete full texts and PDFs are available in Russian, Kazakh and English.

Issue published

Open Access · CC BY 4.0

Review Article · Volume 1 · Issue 1 · e0001

Modern approaches to pharmaceutical manufacturing optimization: integrating Lean, QbD, PAT and Pharma 4.0 into the pharmaceutical quality system

The aim of this narrative review was to compare current approaches to pharmaceutical manufacturing optimization and to define their roles within the pharmaceutical quality system. Relevant scientific publications and regulatory documents were reviewed in PubMed, Scopus and Web of Science and supplemented with regulatory documents from ICH, FDA, WHO, PIC/S and the European Commission; the last search was conducted on…

pharmaceutical manufacturingpharmaceutical quality systemLeanSix SigmaQuality by DesignProcess Analytical Technology

Read article

Original Research Article · Volume 1 · Issue 1 · e0002

Development of the DoseProof system for medication monitoring with video confirmation and family support

Suboptimal adherence to long-term pharmacotherapy remains a significant problem, highlighting the need to develop digital tools that support adherence to medication regimens and enable the timely identification of unconfirmed medication-taking events.

medication adherencedrug therapymobile applicationsmedication therapy managementDoseProofvideo recording

Read article

Review Article · Volume 1 · Issue 1 · e0003

Artificial intelligence in GxP-regulated pharmaceutical activities: regulatory requirements, validation, data governance and risk management

Introduction. The digital transformation of the pharmaceutical industry, together with the development of Process Analytical Technology (PAT), continuous manufacturing, and the Pharma 4.0 concept, has created favorable conditions for the broader application of artificial intelligence (AI) and machine learning (ML) in pharmaceutical development, manufacturing, quality control, and other GxP-regulated processes. At th…

artificial intelligencemachine learningGxPpharmaceutical manufacturingvalidationdata governance

Read article

Review Article · Volume 1 · Issue 1 · e0004

Corn germ oil (Zea mays L.) in the development of dermatological semisolid dosage forms: composition, technological aspects and prospects for application

Corn germ oil (Zea mays L.) is of interest for the development of dermatological semisolid dosage forms because of its high content of unsaturated fatty acids, tocopherols and phytosterols. Its technological and functional properties depend on the composition of the raw material, the method of production, the degree of purification and oxidative stability.

corn germ oilZea mays L.semisolid dosage formsdermatologylinoleic acidtocopherols

Read article

Original Research Article · Volume 1 · Issue 1 · e0005

Development of a technology for obtaining a substance from Glycyrrhiza glabra L. roots by sequential extraction

Differences in the physicochemical properties of biologically active compounds in Glycyrrhiza glabra L. roots, including triterpene saponins, flavonoids and other natural compounds, make their extraction with a single extraction system difficult. A sequential technological approach using extractants of different composition is therefore relevant.

Glycyrrhiza glabra L.licoriceglycyrrhizic acidliquiritinflavonoidssequential extraction

Read article